1673-4157
2012 Issue 1
Influence and mechanism of statins on diabetes
SUN Hong-xi;CHANG Bao-cheng;CHEN Li-ming;FANG Pei-hua
SUN Hong-xi;CHANG Bao-cheng;CHEN Li-ming;FANG Pei-hua
..............page:26-28
Chemokines CXCL9 and diabetic nephropathy
LI Jing;WANG Qiu-yue
LI Jing;WANG Qiu-yue
..............page:24-25,31
Expression of somatostatin receptors in pituitary adenomas and implications for drug research
AO Jing-sheng;GU Feng
AO Jing-sheng;GU Feng
..............page:32-34
Mechanism of insulin resistance of islet cell in type 2 diabetes mellitus
XIN Huan-huan;XI Guang-xia
XIN Huan-huan;XI Guang-xia
..............page:47-49
The reversible analysis of cognitive impairments caused by primary hypothyroidism
ZHANG Yuan-yuan;WANG Lu-ning;XIE Heng-ge
ZHANG Yuan-yuan;WANG Lu-ning;XIE Heng-ge
..............page:15-17
Correlation of different measurements of obesity and uric acid levels in males with abdominally obese
WANG Rui;LU Qiang;FENG Ji;YIN Fu-zai;LIU Bo;MA Chun-ming;QIN Chun-mei
WANG Rui;LU Qiang;FENG Ji;YIN Fu-zai;LIU Bo;MA Chun-ming;QIN Chun-mei
..............page:12-14,20
Epigenetic,diabetes and its complications
YANG Mei;SUN Jia-zhong
YANG Mei;SUN Jia-zhong
..............page:56-58
Insulin resistance and nonalcoholic fatty liver disease
ZHANG Xue-li;XI Guang-xia;ZHAO Yuan-yuan
ZHANG Xue-li;XI Guang-xia;ZHAO Yuan-yuan
..............page:59-61
Effects of early intensive insulin treatment on islet β cell function in type 2 diabetic patients
ZHAO Yu-zhen;BI Chang-hua;SUN Zhi-xia;HAN Jie;REN Kang;ZHANG Chao-yun;ZHANG Xin;XU Jing
ZHAO Yu-zhen;BI Chang-hua;SUN Zhi-xia;HAN Jie;REN Kang;ZHANG Chao-yun;ZHANG Xin;XU Jing
..............page:9-11
The expression and regulation of glucose transporter in diabetic myocardial cell
GUO Qing-hua;XI Guang-xia
GUO Qing-hua;XI Guang-xia
..............page:44-46
tang niao bing shen bing yan jiu jin zhan di 47 jie ou zhou tang niao bing xue hui nian hui zhuan ti bao dao
zhou hui chao ; dong yan hu ; zhang lei
zhou hui chao ; dong yan hu ; zhang lei
..............page:69-70
..............page:1-4
..............page:8,23,37,71,72
The cardioprotective effect of glucagon-like peptide-1
LIU Jie-yu;LIU Yu;WANG Lu
LIU Jie-yu;LIU Yu;WANG Lu
..............page:35-37
Thyroglobulin gene mutation and congenital hypothyroidism
ZHANG Sha-sha;KONG Bin;LIU Shi-guo;LI Wen-jie;ZHANG Li-qin;ZHENG Guo-hua;YAN Sheng-li
ZHANG Sha-sha;KONG Bin;LIU Shi-guo;LI Wen-jie;ZHANG Li-qin;ZHENG Guo-hua;YAN Sheng-li
..............page:62-64,67
Relationship of vaspin and endocrine related diseases
YU Hong-yan;DI Fu-sheng
YU Hong-yan;DI Fu-sheng
..............page:41-43
Glucagon-like peptide-1 and appetite regulation in the hypothalamus
CHEN Yao;XI Guang-xia
CHEN Yao;XI Guang-xia
..............page:38-40
Mindin:a new biomarker of podocyte injury in diabetic nephropathy
LIAO Yu;XIA Ning
LIAO Yu;XIA Ning
..............page:18-20
Effect of different glycemic index diets on diseases
XU Hui;LU Ying-li
XU Hui;LU Ying-li
..............page:29-31
Connective tissue growth factor, diabetic renal fibrosis and its gene interference
FU Yu;WANG Qiu-yue
FU Yu;WANG Qiu-yue
..............page:21-23
di xue tang de yan jiu jin zhan di 71 jie mei guo tang niao bing xie hui nian hui zhuan ti bao dao
zhao fei fei ; zhang lei ; dong yan hu
zhao fei fei ; zhang lei ; dong yan hu
..............page:68-69
Oxidative stress and Graves\' ophthalmopathy
YE Xiao-zhen;WANG Jian
YE Xiao-zhen;WANG Jian
..............page:65-67
Changes of angiogenesis-related factors in type 2 diabetic patients with lower extremity angiopathy
WANG Li-li;ZHUGE Xin;CHEN Yi-ling;ZHANG Yun
WANG Li-li;ZHUGE Xin;CHEN Yi-ling;ZHANG Yun
..............page:5-8
Melatonin,its receptor and type 2 diabetes
SUN Dong;LI Ming-long
SUN Dong;LI Ming-long
..............page:50-52
CXC chemokine ligand 10 and type 1 diabetes mellitus
ZENG Feng-yan;SONG Wen-hui;CHEN Xiao-juan
ZENG Feng-yan;SONG Wen-hui;CHEN Xiao-juan
..............page:53-55